Mullen, A. B., Lawrence, C. E., McFarlane, E., Wei, X., & Carter, K. C. (2006). Endogenous interleukin-18 is involved in immunity to Leishmania donovani but its absence does not adversely influence the therapeutic activity of sodium stibogluconate. Blackwell Science Inc.
Chicago Style CitationMullen, Alexander B., Catherine E. Lawrence, Emma McFarlane, Xiao-Quing Wei, i Katharine C. Carter. Endogenous Interleukin-18 Is Involved in Immunity to Leishmania Donovani but Its Absence Does Not Adversely Influence the Therapeutic Activity of Sodium Stibogluconate. Blackwell Science Inc, 2006.
Cita MLAMullen, Alexander B., et al. Endogenous Interleukin-18 Is Involved in Immunity to Leishmania Donovani but Its Absence Does Not Adversely Influence the Therapeutic Activity of Sodium Stibogluconate. Blackwell Science Inc, 2006.